30 / 88
30
Scientific Programme /
Monday, 19 June 2017
WFSBP 2017
MON
T4: ANXIETY DISORDERS: BASIC/ CLINICAL
S-24
SYMPOSIUM
11:15–12:45
B3 M3-M4
Serotonin and anxiety disorders: Recent evidences
from neuroimaging studies
Chair:
Eduard Maron, Estonia
Co-Chair: Tomas Furmark, Sweden
001
Serotonin system and panic disorder
Eduard Maron, Estonia
002
Serotonin system and social anxiety disorder
Tomas Furmark, Sweden
003
Serotonin system and obsessive-compulsive
disorder
Oliver Pogarell, Germany
004
Serotonin regulation of anxiety neuronal network
Andreas Frick, Sweden
T47: STIMULATION METHODS (ECT, TMS, VNS, DBS)
WS-03
WORKSHOP
11:15–12:45
B3 M1-M2
Current status of electroconvulsive therapy in the
treatment of major psychiatric disorders
Chair:
Yong-Sik Kim, Republic of Korea
Co-Chair: Pascal Sienaert, Belgium
001
Current status on efficacy of ECT
Hans Mørch Jensen, Denmark
002
Mechanism of ECT focused on psychosis
Ung-Gu Kang, Republic of Korea
003
ECT for the treatment resistant psychosis
In-Won Chung, Republic of Korea
004
ECT in catatonia
Pascal Sienaert, Belgium
P-01
POSTER TOUR
13:00–14:30
Congress Hall A 1
Addictive disorders
Chair:
Fabricio Moreira, Brazil
001
Investigating the role of one-carbon metabolism
pathway in complicated alcohol withdrawal states
Karishma Kulkarni, India
M. Purushottam, P. Sharma, B. Viswanath, P. Chand,
S. Jain, P. Murthy
002
Binge drinking, mood and psychological well
being in university students
Thomas Heffernan, United Kingdom
003
Brain activation patterns associated with cue
reactivity in Internet gaming disorder
Dai Jin Kim, Republic of Korea
J.-E. Jeong, J.-W. Chun, H. Cho
006
The study on antidepressant-like effect of
Acamprosate for depression with alcohol use disorder
Masaya Tayama, Japan
T. Saito
010
Study of dopamine transporter gene DAT1 /
SLC6A3 Variable Number of Tandem Repeats (VNTR)
polymorphism in complicated alcohol withdrawal and
alcohol dependence syndrome in South Indian popula-
tion: Case-control Genetic Association study
Brij Kishore, Australia
P. Murthy, S. Jain, V. Benegal, M. Purushottam,
K. Thennarasu, S. Devasenapathy, B. Shankarappa,
A. Dahale
011
DNA methylation signatures of chronic alcohol
dependence in purified CD3+ T cells of patients under-
going alcohol treatment
Vanessa Nieratschker, Germany
C. Brückmann, S. Islam, A. Batra, M. Kobor
014
Reduced amplitude of executive control and front
parietal networks reflects duration of illness in gambling
disorder patients
Kosuke Tsurumi, Japan
R. Kawada, J. Miyata, T. Murai, H. Takahashi
015
Prescription opioid abuse disorder, comparing
outcomes of different approaches
Susana Patricia Gomes da Costa, Spain
G. Anmella, A. Giménez, J. E. Pinzón, C. Oliveras,
P. Bruguera, P. Barrio, A. López, S. Mondon, M. Balcells,
A. Lligoña
017
A new vaccine for cocaine addiction: Preliminary
results of the UFMG-VAC4N2 molecule
Frederico Garcia, Brazil
P. Augusto, Â. de Fátima, L. Silva Neto, A. Godin,
A. Freitas
020
Hair cortisol concentration as risk marker for
increased alcohol use following traumatic experiences
Sebastian Trautmann, Germany
M. Muehlhan, S. Steudte-Schmiedgen
023
Poor sleep quality and suicide attempt among
adults with internet addiction: A nationwide community
sample of Korea
Eun-Jin Na, Republic of Korea
K. Kim, H. Lee, H.-J. Jeon